Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor
Copyright 2000 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2000
In Reply: Mr Teglas and colleagues raise the
important issue of selection bias in longitudinal studies to estimate the
survival of HIV-infected individuals and suggest that our study's estimated
cumulative probability of survival, which is lower than that reported elsewhere,
may have been affected by such a bias. Although we agree that enrolling all
children at birth would represent an improvement, the ideal study would enroll
a very large sample of HIV-infected women and follow up those who became pregnant
and, afterward, their children.
Pezzotti P, Rezza G, Balducci M, Tovo P, Gabiano C, Galli L, de Martino M, . Antiretroviral Therapy and Mortality Among Children With Perinatal HIV Infection—Reply. JAMA. 2000;284(22):2871-2872. doi:10.1001/jama.284.22.2869